BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31189468)

  • 1. Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models.
    Lee SH; Kim S; Lee N; Lee J; Yu SS; Kim JH; Kim S
    Acta Neuropathol Commun; 2019 Jun; 7(1):96. PubMed ID: 31189468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular delivery of HGF-expressing recombinant AAV improves muscle integrity and alleviates neurological symptoms in the nerve crush and SOD1-G93A transgenic mouse models.
    Lee SH; Lee N; Kim S; Lee J; Choi W; Yu SS; Kim JH; Kim S
    Biochem Biophys Res Commun; 2019 Sep; 517(3):452-457. PubMed ID: 31376938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crush injury to motor nerves in the G93A transgenic mouse model of amyotrophic lateral sclerosis promotes muscle reinnervation and survival of functionally intact nerve-muscle contacts.
    Sharp PS; Tyreman N; Jones KE; Gordon T
    Neurobiol Dis; 2018 May; 113():33-44. PubMed ID: 29409912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
    Aoki M; Warita H; Suzuki N; Itoyama Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (
    Wang S; Ichinomiya T; Savchenko P; Wang D; Sawada A; Li X; Duong T; Li W; Bonds JA; Kim EJ; Miyanohara A; Roth DM; Patel HH; Patel PM; Tadokoro T; Marsala M; Head BP
    Theranostics; 2022; 12(12):5389-5403. PubMed ID: 35910808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyotrophic lateral sclerosis with the SOD1 mutations].
    Aoki M; Warita H; Itoyama Y
    Rinsho Shinkeigaku; 2008 Nov; 48(11):966-9. PubMed ID: 19198133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya-Shimada W; Nakamura T; Matsumoto K; Matsuyama S; Nakamura T
    Neurosci Res; 2009 Oct; 65(2):194-200. PubMed ID: 19595710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS; Dick JR; Greensmith L
    Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2.
    Azzouz M; Hottinger A; Paterna JC; Zurn AD; Aebischer P; Büeler H
    Hum Mol Genet; 2000 Mar; 9(5):803-11. PubMed ID: 10749988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis.
    Joshi AR; Muke I; Bobylev I; Lehmann HC
    J Comp Neurol; 2019 Oct; 527(14):2334-2340. PubMed ID: 30861116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
    Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
    Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal delivery of AAV-NDNF ameliorates disease progression of ALS mice.
    Cheng W; Huang J; Fu XQ; Tian WY; Zeng PM; Li Y; Luo ZG
    Mol Ther; 2023 Nov; 31(11):3277-3289. PubMed ID: 37766430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epothilone D accelerates disease progression in the SOD1
    Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
    Rocha MC; Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
    PLoS One; 2013; 8(9):e73846. PubMed ID: 24040091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.